Back to Search Start Over

Diabetes Rescue, Engagement and Management (D-REM): rationale and design of a pragmatic clinical trial of a community paramedicine programme to improve diabetes care.

Authors :
Juntunen MB
Liedl CP
Carlson PN
Myers LA
Stickler ZR
Ryan Schultz JA
Meilander AK
Behnken E
Lampman MA
Rogerson MC
Fischer KM
McCoy RG
Source :
BMJ open [BMJ Open] 2022 Apr 21; Vol. 12 (4), pp. e057224. Date of Electronic Publication: 2022 Apr 21.
Publication Year :
2022

Abstract

Introduction: Diabetes is one of the most common serious chronic health conditions in the USA. People living with diabetes face multiple barriers to optimal diabetes care, including gaps in access to medical care and self-management education, diabetes distress, and high burden of treatment. Community paramedics (CPs) are uniquely positioned to support multidisciplinary care for patients with diabetes by delivering focused diabetes self-management education and support and bridging the gaps between patients and the clinical and community resources they need to live well with their disease.<br />Methods and Analysis: We will conduct a pragmatic single-arm prospective trial of a CP-led Diabetes Rescue, Engagement and Management (D-REM) programme that seeks to reduce diabetes distress. We will enrol 70 adults (≥18 years) with diabetes who have haemoglobin A1c (HbA1c)≥9.0%, experienced an emergency department (ED) visit or hospitalisation for any cause within the prior 6 months, and reside in areas with available CP support in Southeast Minnesota (Olmsted, Freeborn and Mower counties) and Northwest Wisconsin (Barron, Rusk and Dunn counties). Participants will be identified using Mayo Clinic electronic health records, contacted for consent and enrolled into the D-REM programme. Visit frequency will be individualised for each patient, but will be an average of four CP visits over the course of approximately 1 month. Outcomes will be change in diabetes distress (primary outcome), confidence in diabetes self-management, health-related quality of life, self-reported hypoglycaemia and hyperglycaemia, HbA1c, ED visits and hospitalisations. Outcomes will be assessed on enrolment, programme completion and 3 months after programme completion.<br />Ethics and Dissemination: The study was approved by Mayo Clinic Institutional Review Board. Findings will be disseminated through peer-reviewed publications and presentations. If demonstrated to be successful, this model of care can be implemented across diverse settings and populations to support patients living with diabetes.<br />Trial Registration Number: NCT04385758.<br />Competing Interests: Competing interests: In the last 36 months, RGM received support from NIDDK, PCORI and AARP. She also serves as a consultant to Emmi (Wolters Kluwer) on developing patient education materials related to diabetes.<br /> (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
2044-6055
Volume :
12
Issue :
4
Database :
MEDLINE
Journal :
BMJ open
Publication Type :
Academic Journal
Accession number :
35450906
Full Text :
https://doi.org/10.1136/bmjopen-2021-057224